首頁 › 骨髓增生性腫瘤 › 阿拉巴馬州 › Birmingham
Birmingham, AL 的 骨髓增生性腫瘤 臨床試驗
8 項針對 骨髓增生性腫瘤 的研究正在 Birmingham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- University of Alabama at Birmingham Cancer Center, Birmingham
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- University of Alabama at Birmingham Cancer Center, Birmingham
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- Children's Hospital of Alabama, Birmingham
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
招募中1 期
- University of Alabama At Birmingham, Birmingham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
招募中2 期
- University of Alabama Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Birmingham
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
招募中2 期
- University of Alabama at Birmingham, Birmingham
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
招募中2 期
- University of Alabama at Birmingham, Birmingham
其他城市的 骨髓增生性腫瘤 試驗
- Houston, TX16 項研究
- New York City, NY15 項研究
- Boston, MA14 項研究
- Milwaukee, WI10 項研究
- Miami, FL10 項研究
- Durham, NC9 項研究
- Baldwin Park, CA9 項研究
- Seattle, WA9 項研究
- Chicago, IL9 項研究
- Portland, OR8 項研究
- Cleveland, OH8 項研究
- Atlanta, GA8 項研究
Birmingham 的其他研究
- 癌症（所有類型）31 項研究
- 乳癌24 項研究
- 卵巢癌23 項研究
- 肥胖症23 項研究
- 非小細胞肺癌22 項研究
- 急性髓系白血病21 項研究
- 多發性骨髓瘤18 項研究
- 慢性阻塞性肺病17 項研究
- 心血管疾病17 項研究
- 第二型糖尿病16 項研究
- 子宮內膜癌16 項研究
- 過重16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。